Park JW - Search Results

1

Associations of ErbB2, beta1-integrin and lipid rafts on Herceptin (Trastuzumab) resistant and sensitive tumor cell lines.

Mocanu MM, Fazekas Z, Petrás M, Nagy P, Sebestyén Z, Isola J, Tímár J, Park JW, Vereb G, Szöllosi J. Mocanu MM, et al. Among authors: park jw. Cancer Lett. 2005 Sep 28;227(2):201-12. doi: 10.1016/j.canlet.2005.01.028. Cancer Lett. 2005. PMID: 16112423

2

Characterization of a novel, trastuzumab resistant human breast cancer cell line.

Barok M, Balazs M, Lazar V, Rakosy Z, Toth E, Treszl A, Vereb G, Colbern GT, Park JW, Szollosi J. Barok M, et al. Among authors: park jw. Front Biosci (Elite Ed). 2010 Jan 1;2(2):627-40. doi: 10.2741/e119. Front Biosci (Elite Ed). 2010. PMID: 20036907 Free article.

3

Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2.

Nagy P, Vereb G, Sebestyén Z, Horváth G, Lockett SJ, Damjanovich S, Park JW, Jovin TM, Szöllosi J. Nagy P, et al. Among authors: park jw. J Cell Sci. 2002 Nov 15;115(Pt 22):4251-62. doi: 10.1242/jcs.00118. J Cell Sci. 2002. PMID: 12376557

4

Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor.

Barok M, Balázs M, Nagy P, Rákosy Z, Treszl A, Tóth E, Juhász I, Park JW, Isola J, Vereb G, Szöllosi J. Barok M, et al. Among authors: park jw. Cancer Lett. 2008 Feb 18;260(1-2):198-208. doi: 10.1016/j.canlet.2007.10.043. Epub 2007 Dec 21. Cancer Lett. 2008. PMID: 18096313

5

Applications of fluorescence resonance energy transfer for mapping biological membranes.

Szöllosi J, Nagy P, Sebestyén Z, Damjanovicha S, Park JW, Mátyus L. Szöllosi J, et al. Among authors: park jw. J Biotechnol. 2002 Jan;82(3):251-66. doi: 10.1016/s1389-0352(01)00041-1. J Biotechnol. 2002. PMID: 11999693 Review.

6

Selecting the right fluorophores and flow cytometer for fluorescence resonance energy transfer measurements.

Horváth G, Petrás M, Szentesi G, Fábián A, Park JW, Vereb G, Szöllosi J. Horváth G, et al. Among authors: park jw. Cytometry A. 2005 Jun;65(2):148-57. doi: 10.1002/cyto.a.20142. Cytometry A. 2005. PMID: 15825180 Free article.

7

Novel calibration method for flow cytometric fluorescence resonance energy transfer measurements between visible fluorescent proteins.

Nagy P, Bene L, Hyun WC, Vereb G, Braun M, Antz C, Paysan J, Damjanovich S, Park JW, Szöllősi J. Nagy P, et al. Among authors: park jw. Cytometry A. 2005 Oct;67(2):86-96. doi: 10.1002/cyto.a.20164. Cytometry A. 2005. PMID: 16163690 Free article.

8

Unraveling the biologic and clinical complexities of HER2.

Park JW, Neve RM, Szollosi J, Benz CC. Park JW, et al. Clin Breast Cancer. 2008 Oct;8(5):392-401. doi: 10.3816/CBC.2008.n.047. Clin Breast Cancer. 2008. PMID: 18952552 Review.

9

Anti-HER2 immunoliposomes for targeted therapy of human tumors.

Park JW, Hong K, Kirpotin DB, Meyer O, Papahadjopoulos D, Benz CC. Park JW, et al. Cancer Lett. 1997 Oct 14;118(2):153-60. doi: 10.1016/s0304-3835(97)00326-1. Cancer Lett. 1997. PMID: 9459205

10

Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.

Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, Marks JD, Benz CC, Park JW. Kirpotin DB, et al. Among authors: park jw. Cancer Res. 2006 Jul 1;66(13):6732-40. doi: 10.1158/0008-5472.CAN-05-4199. Cancer Res. 2006. PMID: 16818648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,082 results

Search Page

Filters